Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 180

1.

Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression.

Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E.

Mod Pathol. 2013 Dec;26(12):1568-76. doi: 10.1038/modpathol.2013.106. Epub 2013 Jun 14.

2.

Marginal zone lymphomas involving meningeal dura: possible link to IgG4-related diseases.

Venkataraman G, Rizzo KA, Chavez JJ, Streubel B, Raffeld M, Jaffe ES, Pittaluga S.

Mod Pathol. 2011 Mar;24(3):355-66. doi: 10.1038/modpathol.2010.206. Epub 2010 Nov 19.

3.

Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.

Edinger JT, Kant JA, Swerdlow SH.

Am J Surg Pathol. 2010 Dec;34(12):1830-41. doi: 10.1097/PAS.0b013e3181f72835.

PMID:
21107089
4.

Characteristics of cutaneous marginal zone lymphomas with marked plasmacytic differentiation and a T cell-rich background.

Geyer JT, Ferry JA, Longtine JA, Flotte TJ, Harris NL, Zukerberg LR.

Am J Clin Pathol. 2010 Jan;133(1):59-69. doi: 10.1309/AJCPW64FFBTTPKFN.

PMID:
20023259
5.

Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma.

Cerroni L, Signoretti S, Höfler G, Annessi G, Pütz B, Lackinger E, Metze D, Giannetti A, Kerl H.

Am J Surg Pathol. 1997 Nov;21(11):1307-15.

PMID:
9351568
6.

Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.

Servitje O, Muniesa C, Benavente Y, Monsálvez V, Garcia-Muret MP, Gallardo F, Domingo-Domenech E, Lucas A, Climent F, Rodriguez-Peralto JL, Ortiz-Romero PL, Sandoval J, Pujol RM, Estrach MT.

J Am Acad Dermatol. 2013 Sep;69(3):357-65. doi: 10.1016/j.jaad.2013.04.047. Epub 2013 Jun 21.

PMID:
23796549
7.

Blastic marginal zone lymphoma: a clinical and pathological study of 8 cases and review of the literature.

Magro CM, Yang A, Fraga G.

Am J Dermatopathol. 2013 May;35(3):319-26. doi: 10.1097/DAD.0b013e318267495f. Review.

PMID:
23190506
8.

IgG4-producing marginal zone B-cell lymphoma.

Sato Y, Takata K, Ichimura K, Tanaka T, Morito T, Tamura M, Yoshino T.

Int J Hematol. 2008 Nov;88(4):428-33. doi: 10.1007/s12185-008-0170-8. Epub 2008 Oct 8.

PMID:
18839275
9.

Primary cutaneous marginal IgG4 lymphoma and Rosai-Dorfman's disease coexisting in several lesions of the same patient.

Machan S, Medina C, Rodríguez-Pinilla SM, Suárez-Peñaranda JM, Castro Y, Molés P, Requena C, Saus C, Requena L, Santonja C.

Am J Dermatopathol. 2015 May;37(5):413-8. doi: 10.1097/DAD.0000000000000249. Review.

PMID:
25590288
10.

Marginal zone lymphomas in children and the young adult population; characterization of genetic aberrations by FISH and RT-PCR.

Rizzo KA, Streubel B, Pittaluga S, Chott A, Xi L, Raffeld M, Jaffe ES.

Mod Pathol. 2010 Jun;23(6):866-73. doi: 10.1038/modpathol.2010.63. Epub 2010 Mar 19.

11.

Cutaneous lymphoid hyperplasia and cutaneous marginal zone lymphoma: comparison of morphologic and immunophenotypic features.

Baldassano MF, Bailey EM, Ferry JA, Harris NL, Duncan LM.

Am J Surg Pathol. 1999 Jan;23(1):88-96.

PMID:
9888708
12.

Clonal identity and differences in primary cutaneous B-cell lymphoma occurring at different sites or time points in the same patient.

Fujiwara M, Morales AV, Seo K, Kim YH, Arber DA, Sundram UN.

Am J Dermatopathol. 2013 Feb;35(1):11-8. doi: 10.1097/DAD.0b013e318255dbae.

PMID:
22588547
13.

MicroRNAs as prognostic markers in indolent primary cutaneous B-cell lymphoma.

Monsálvez V, Montes-Moreno S, Artiga MJ, Rodríguez ME, Sanchez-Espiridion B, Lozano M, Fernández-de-Misa R, Rodríguez-Peralto JL, Piris MA, Ortíz-Romero PL.

Mod Pathol. 2013 Feb;26(2):171-81. doi: 10.1038/modpathol.2012.149. Epub 2012 Aug 31. Erratum in: Mod Pathol. 2013 Apr;26(4):617. Espiridión, Beatriz S [corrected to Sanchez-Espiridion, Beatriz].

14.

Evaluating breast lymphoplasmacytic infiltrates: a multiparameter immunohistochemical study, including assessment of IgG4.

Berg AN, Soma L, Clark BZ, Swerdlow SH, Roth CG.

Hum Pathol. 2015 Aug;46(8):1162-70. doi: 10.1016/j.humpath.2015.04.006. Epub 2015 Apr 28.

PMID:
26026200
15.

Ocular adnexal marginal zone B cell lymphoma infiltrated by IgG4-positive plasma cells.

Kubota T, Moritani S, Yoshino T, Nagai H, Terasaki H.

J Clin Pathol. 2010 Dec;63(12):1059-65. doi: 10.1136/jcp.2010.082156. Epub 2010 Oct 27.

16.

Clinicopathological Analysis of Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma with IgG4-Positive Cells.

Lee MJ, Kim N, Choe JY, Khwarg SI, Jeon YK, Choung HK, Kim JE.

PLoS One. 2015 Jun 25;10(6):e0131458. doi: 10.1371/journal.pone.0131458. eCollection 2015.

17.
18.

Applying the new TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sézary syndrome in primary cutaneous marginal zone lymphoma.

Gerami P, Wickless SC, Rosen S, Kuzel TM, Ciurea A, Havey J, Guitart J.

J Am Acad Dermatol. 2008 Aug;59(2):245-54. doi: 10.1016/j.jaad.2008.04.012. Epub 2008 May 16.

PMID:
18486274
19.

Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.

de Leval L, Harris NL, Longtine J, Ferry JA, Duncan LM.

Am J Surg Pathol. 2001 Jun;25(6):732-41.

PMID:
11395550
20.

Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.

Bailey EM, Ferry JA, Harris NL, Mihm MC Jr, Jacobson JO, Duncan LM.

Am J Surg Pathol. 1996 Aug;20(8):1011-23.

PMID:
8712288

Supplemental Content

Support Center